BAP-1 likewise demonstrated exceptional glioma selectivity: thirty minutes post-injection, tumor fluorescence exceeded background by more than 2400-fold in PFA-fixed 15 μm slices and ~85-fold in live 300 μm slices (Figure 5 and Figure 6). Here, BAP1 is linked to glioma.